Community intervention curbs CV disease in hypertensive adults
Nonphysician health workers helped patients control hypertension and reduce cardiovascular disease risk.
Over decades, low physical activity boosts mortality risk
PARIS – Being active in earlier adulthood didn’t save sedentary older adults from increased risk.
Disputes over malpractice blame: Do allocations matter?
A legal battle between a doctor and insurer highlight conflicts that can arise when settling medical malpractice claims.
Quarterly intravenous eptinezumab prevents migraine
PHILADELPHIA – Results from a pair of dose-ranging, randomized studies showed one IV eptinezumab dose cut migraine recurrences for 3 months.
Nearly 20% of migraineurs use opioids for migraine
PHILADELPHIA – People with 4 or more migraine headache days per month are more likely to use opioids, compared with people with fewer migraine...
Overreliance on DAS scores undermines rheumatoid arthritis management
MADRID – A rheumatoid arthritis patient says “DAS blindness” now pervades rheumatoid arthritis management and degrades care.
Tanezumab improves osteoarthritis pain, function in phase 3 trial
MADRID – Trial showed strong differences in response to active treatment versus placebo despite being tested in “a difficult-to-treat population...
Refractory RA responds to vagus nerve stimulation
MADRID – Pilot trial of a vagus nerve stimulator device shows relative safety and signs of efficacy over 12 weeks.
Bisphosphonates before denosumab may prevent postdenosumab BMD rebound effect
MADRID – Preliminary results suggest that using denosumab after bisphosphonates for rebound is effective and monitoring bone turnover markers at...
Ultra low-dose rituximab retains promise in rheumatoid arthritis